CRISPR Therapeutics outlines 2026 milestones with $2 billion cash

Go back to CRISPR Therapeutics outlines 2026 milestones with $2 billion cash
(NASDAQ: CRSP) Delayed: 56.82 -0.16 (0.28%)
Previous Close $56.98    52 Week High $18.88 
Open $56.22    52 Week Low $13.75 
Day High $57.13    P/E N/A 
Day Low $55.43    EPS $0.00 
Volume 890,775